Xylem reported Q3 2025 revenue of $2.27 billion and net income of $227 million. Adjusted EPS surged 23% to $1.37, driven by strong demand, pricing, and operational efficiency. Net income margin was 10.0%.
Revenue reached $2.27 billion, up 8% year-over-year, with all segments contributing to growth.
Adjusted EBITDA margin expanded to a record 23.2%, supported by pricing and productivity gains.
Net income was $227 million, with EPS at $0.93; adjusted EPS rose to $1.37.
Free cash flow for the quarter was negative due to $248 million in capital expenditures.
Xylem raised its full-year 2025 guidance, expecting higher revenue and adjusted EPS based on strong Q3 execution and demand.
Visualization of income flow from segment revenue to net income